Secondary primary malignancy and radioiodine administration in differentiated thyroid cancer patients: a second check

被引：0
|
作者：
Volpe, F. [1 ]
Piscopo, L. [1 ]
Manganelli, M. [1 ]
Nappi, C. [1 ]
Zampella, E. [1 ]
Gaudieri, V. [1 ]
Volpicelli, F. [1 ]
Klain, M. [1 ]
Maurea, S. [1 ]
Cuocolo, A. [1 ]
机构：
[1] Univ Federico II, Dept Adv Biomed Sci, Naples, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2022年 / 49卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-530
引用
收藏
页码：S175 / S176
页数：2
相关论文
共 50 条
  • [41] Guidelines for radioiodine therapy in differentiated thyroid cancer
    Dietlein, M
    Dressler, J
    Farahati, J
    Leisner, B
    Moser, E
    Reiners, C
    Schicha, H
    Schober, O
    NUKLEARMEDIZIN, 1999, 38 (6A) : 221 - 222
  • [42] Conventional Radioiodine Therapy for Differentiated Thyroid Cancer
    Ylli, Donna
    Van Nostrand, Douglas
    Wartofsky, Leonard
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2019, 48 (01) : 181 - +
  • [43] Respiratory distress caused by radioiodine therapy in patients with differentiated thyroid cancer
    Kinuya, Seigo
    Yokoyama, Kunihiko
    Michigisuh, Takatoshi
    Tonami, Norihisa
    ANNALS OF NUCLEAR MEDICINE, 2006, 20 (07) : 499 - 502
  • [44] Prognostic significance of successful ablation with radioiodine of differentiated thyroid cancer patients
    Verburg, FA
    de Keizer, B
    Lips, CJM
    Zelissen, PMJ
    de Klerk, JMH
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2005, 152 (01) : 33 - 37
  • [45] Respiratory distress caused by radioiodine therapy in patients with differentiated thyroid cancer
    Seigo Kinuya
    Kunihiko Yokoyama
    Takatoshi Michigishi
    Norihisa Tonami
    Annals of Nuclear Medicine, 2006, 20
  • [46] The efficacy of low dose radioiodine therapy in differentiated thyroid cancer patients
    Yoon, S.
    Choi, B.
    Hong, S.
    Joh, C.
    Yoon, J.
    Lee, K.
    So, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S374 - S374
  • [47] INFLUENCE OF HYDROCHLOROTHIAZIDE ON URINARY EXCRETION OF RADIOIODINE IN PATIENTS WITH DIFFERENTIATED THYROID CANCER
    Ignjatovic, V. D.
    Vukomanovic, V.
    Jeremic, M.
    Ignjatovic, V. S.
    Matovic, M.
    ACTA ENDOCRINOLOGICA-BUCHAREST, 2015, 11 (03) : 396 - 400
  • [48] Impact of age on survival in radioiodine refractory differentiated thyroid cancer patients
    Saie, C.
    Wassermann, J.
    Mathy, E.
    Chereau, N.
    Leenhardt, L.
    du Montcel, S. Tezenas
    Buffet, C.
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2021, 184 (05) : 667 - 676
  • [49] Second primary malignancy risk in thyroid cancer and matched patients with and without radioiodine therapy analysis from the observational health data sciences and informatics
    Kim, Seok
    Bang, Ji-In
    Boo, Dachung
    Kim, Borham
    Choi, In Young
    Ko, SooJeong
    Yoo, Ie Ryung
    Kim, Kwangsoo
    Kim, Junmo
    Joo, YoungHwan
    Ryoo, Hyun Gee
    Paeng, Jin Chul
    Park, Jung Mi
    Jang, Woncheol
    Kim, Byungwon
    Chung, Yangha
    Yang, Dongyoon
    Yoo, Sooyoung
    Lee, Ho-Young
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (10) : 3547 - 3556
  • [50] Second primary malignancy risk in thyroid cancer and matched patients with and without radioiodine therapy analysis from the observational health data sciences and informatics
    Seok Kim
    Ji-In Bang
    Dachung Boo
    Borham Kim
    In Young Choi
    SooJeong Ko
    Ie Ryung Yoo
    Kwangsoo Kim
    Junmo Kim
    YoungHwan Joo
    Hyun Gee Ryoo
    Jin Chul Paeng
    Jung Mi Park
    Woncheol Jang
    Byungwon Kim
    Yangha Chung
    Dongyoon Yang
    Sooyoung Yoo
    Ho-Young Lee
    European Journal of Nuclear Medicine and Molecular Imaging, 2022, 49 : 3547 - 3556
12345